companydata.dkMammen BioProcess Support ApS: Financial statements 2026
CVR: 43983881
Mammen BioProcess Support ApS (CVR 43983881) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. That is an increase of 19.1% compared with the year before. Equity amounted to DKK 670,757. The solvency ratio was 72.8%.
- Gross Profit
- 1,787,690 kr.
- Profit/Loss
- 362,902 kr.
- Equity
- 670,757 kr.
- Total Assets
- 920,905 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 1.8 mio. | 363 t. | 671 t. | 0 |
| 2025 | - | 1.5 mio. | 261 t. | 308 t. | 0 |
| 2024 | - | 1.6 mio. | 436 t. | 476 t. | 1 |
Keep an eye on Mammen BioProcess Support ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Mammen BioProcess Support ApS
Mammen BioProcess Support ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Max Løjtved Mammen. The company is owned by Max Mammen Holding ApS. In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. Equity amounted to DKK 670,757.